Brief: KORU Medical Systems Announces Novel Therapies Collaboration For Late-Stage Endocrinological Biologic

Koru Medical Systems

27/07/2023 23:17

July 27 (Reuters) - KORU Medical Systems Inc  KRMD.O :
    * KORU MEDICAL SYSTEMS ANNOUNCES NOVEL THERAPIES
COLLABORATION FOR
LATE-STAGE ENDOCRINOLOGICAL BIOLOGIC
    * KORU MEDICAL - AGREEMENT WITH BIOPHARMACEUTICAL COMPANY TO
VALIDATE ITS FREEDOM INFUSION SYSTEM FOR USE WITH BIOPHARMA
COMPANY'S DRUG, NOVEL BIOLOGIC
    * KORU MEDICAL SYSTEMS INC - KORU MEDICAL WILL VALIDATE
FREEDOM
INFUSION SYSTEM FOR USE WITH COMPANY'S DRUG
    * KORU MEDICAL SYSTEMS INC - DRUG DEVELOPER IS EXPECTED TO
BEGIN
PHASE III STUDIES BY END OF 2023 FOR TREATMENT OF A RARE GENETIC
DISEASE

Source text for Eikon:  ID:nBw93NW2qa 
Further company coverage:  KRMD.O 

 (Reuters.Briefs@thomsonreuters.com)